Indefinite Delivery Contract SPE2D220D0090

This Indefinite Delivery Contract (IDC) award from the Defense Logistics Agency (DLA) to Avkare LLC, a for-profit limited liability company based in Pulaski, Tennessee, has a ceiling value of $3,798,662.40 and a period of performance through April 26, 2025. The contract is for the manufacture and distribution of pharmaceutical and medical products, primarily consisting of generic medications such as cephalexin, prednisone, emtricitabine-tenofovir, primaquine phosphate, and sulfamethoxazole-trimethoprim. The products are delivered to various federal healthcare agencies, including the Department of Veterans Affairs (VA), Department of Defense (DoD), Indian Health Service (IHS), and Bureau of Prisons, through the DLA Troop Support Medical and VA National Acquisition Center programs. This IDC was awarded without any small business set-asides, indicating Avkare's ability to compete on an unrestricted basis. The original solicitation was for a national requirements contract for ibuprofen tablets, with the intent to establish a supply source for multiple federal agencies to purchase these pharmaceutical products on an as-needed basis.

Avkare holds several significant IDV contracts with federal agencies, including a $1.637 billion Federal Supply Schedule contract for drugs, pharmaceuticals, and hematology-related products, as well as additional IDCs with DLA and the VA for specific pharmaceutical products like metformin HCL ER tablets, acitretin capsules, and estradiol tablets. These contracts typically have one-year base periods with multiple one-year option periods, allowing the agency customers to issue task and delivery orders as required to support their respective healthcare missions.